EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection

Cengiz PATA ¹ , Aziz YAZAR ² , Kamuran KONCA ³ , Gökhan BİLGİÇ ³ , Gülçin ESKANDARI ⁴ , Candan ÖZTÜRK ⁵

Author Affiliation(s)

1.

Department of Gastroenterology, Yeditepe University Hospital, İstanbul

2.

Departments of Oncology and Gastroenterohepatology, Acıbadem University School of Medicine, İstanbul

3.

Mersin Universty Medical Faculty, Depatments of Internal Medicine, Mersin

4.

Mersin Universty Medical Faculty, Depatments of Biochemistry, Mersin

5.

Mersin Universty Medical Faculty, Depatments of Internal Medicine and Microbiology, Mersin

Turk J Gastroenterol 2002; 13: 6-10

Keywords : Chronic hepatitis B, healthy hepatitis B virus carrier, recombinant hepatitis B vaccine.

Read: 1704 Downloads: 1322 Published: 25 July 2019

Volume 13, Issue 1, March 2002

Previous Article

Files